Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-016613
Filing Date
2022-03-31
Accepted
2022-03-31 13:51:44
Documents
73
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_bioessence.htm   iXBRL 10-K 816915
2 CERTIFICATION f10k2021ex31-1_bioessence.htm EX-31.1 7330
3 CERTIFICATION f10k2021ex31-2_bioessence.htm EX-32.2 7328
4 CERTIFICATION f10k2021ex32-1_bioessence.htm EX-32.1 3758
5 CERTIFICATION f10k2021ex32-2_bioessence.htm EX-31.2 4081
6 GRAPHIC image_001.jpg GRAPHIC 7168
7 GRAPHIC image_002.jpg GRAPHIC 10541
  Complete submission text file 0001213900-22-016613.txt   4213155

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cik00001723059-20211231.xsd EX-101.SCH 53379
9 XBRL CALCULATION FILE cik00001723059-20211231_cal.xml EX-101.CAL 43530
10 XBRL DEFINITION FILE cik00001723059-20211231_def.xml EX-101.DEF 196490
11 XBRL LABEL FILE cik00001723059-20211231_lab.xml EX-101.LAB 387783
12 XBRL PRESENTATION FILE cik00001723059-20211231_pre.xml EX-101.PRE 203366
67 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_bioessence_htm.xml XML 445388
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

EIN.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56263 | Film No.: 22791160
SIC: 2834 Pharmaceutical Preparations